HR 5160
119th Congress
House
Health
Biological and life sciences
Blood and blood diseases
Cell biology and embryology
Health programs administration and funding
Organ and tissue donation and transplantation
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Everywhere this bill has been
16 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 21, 2026
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.
Jul 20, 2026 · 3:09 PM EDT
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
Jul 20, 2026 · 3:09 PM EDT
Considered under suspension of the rules. (consideration: CR H4642-4643)
Jul 20, 2026 · 3:20 PM EDT
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)
Jul 20, 2026 · 3:20 PM EDT
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)
Jul 20, 2026 · 3:09 PM EDT
DEBATE - The House proceeded with forty minutes of debate on H.R. 5160.
Jul 20, 2026 · 3:20 PM EDT
Motion to reconsider laid on the table Agreed to without objection.
Jul 2, 2026
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.
Jul 2, 2026
Placed on the Union Calendar, Calendar No. 629.
May 21, 2026
Committee Consideration and Mark-up Session Held
May 21, 2026
Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
May 13, 2026
Forwarded by Subcommittee to Full Committee by Voice Vote.
May 13, 2026
Subcommittee Consideration and Mark-up Session Held
Sep 4, 2025
Referred to the House Committee on Energy and Commerce.
Sep 4, 2025
Referred to the Subcommittee on Health.
Sep 4, 2025
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
What's happening now
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.
Hearings & markups
1
Related & companion bills
1
Bill text
4 versions
- Engrossed in House Formatted Text PDF Formatted XML
- Introduced in House Formatted Text PDF Formatted XML
- Placed on Calendar Senate Formatted Text PDF Formatted XML
- Reported in House Formatted Text PDF Formatted XML
Committees of jurisdiction
2
Cosponsors
21
D
Davids, Sharice
R
Fitzpatrick, Brian K.
R
Lawler, Michael
D
Vindman, Eugene Simon
R
Finstad, Brad
D
Morrison, Kelly
D
Barragán, Nanette Diaz
R
Bentz, Cliff
D
Castor, Kathy
R
Garbarino, Andrew R.
R
Malliotakis, Nicole
D
Norton, Eleanor Holmes
R
Aderholt, Robert B.
D
Gottheimer, Josh
D
Dingell, Debbie
R
Fischbach, Michelle
R
Bilirakis, Gus M.
D
Matsui, Doris O.
D
Mfume, Kweisi
D
Pingree, Chellie
R
Tenney, Claudia
Cite this page
U.S. Congress. (2026). H.R. 5160: Stem Cell Therapeutic and Research Reauthorization Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-HR-5160/
"H.R. 5160: Stem Cell Therapeutic and Research Reauthorization Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-5160/.
H.R. 5160, 119th Cong. (2026), https://openamerica.io/bill/119-HR-5160/.
[H.R. 5160: Stem Cell Therapeutic and Research Reauthorization Act of 2025](https://openamerica.io/bill/119-HR-5160/)